Hemostats And Tissue Sealants Global Market Report 2025
상품코드:1810910
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
지혈제 및 조직 실란트 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 6.6%로 56억 1,000만 달러로 성장합니다. 외래수술센터(ASC)에서 지혈제 사용 증가, 생체 적합성 실란트 및 합성 실란트에 대한 수요 증가, 수술 기술 혁신 및 연구개발에 대한 투자 확대, 수술 중 혈액 관리에 대한 인식 증가, 의료비 지출 증가 등이 예측 기간 중 성장 요인으로 작용할 것으로 보입니다. 이 기간 중 예상되는 주요 동향으로는 합성 고분자 기술의 발전, 약물전달 기반 실란트의 혁신, 최소 침습 수술에 지혈제의 도입, 이중 기능 실란트 및 지혈제의 발전, 생체 공학 및 생체 적합성 재료의 개발 등이 있습니다.
수술 절차 증가는 지혈제 및 조직 실란트 시장의 성장을 촉진할 것으로 예측됩니다. 외과수술은 외과 의사가 병든 조직이나 장기를 진단, 치료, 절제하거나 신체 기능을 회복시키기 위해 시행하는 시술이나 기구를 이용한 시술을 포함합니다. 이러한 시술 증가는 적절한 관리, 치료 및 합병증 예방을 위해 외과적 개입이 자주 필요한 만성질환의 유병률 증가에 기인합니다. 지혈제 및 조직 실란트는 이러한 시술에서 출혈을 효과적으로 제어하고 조직을 밀봉하여 합병증을 최소화하고 수술 결과를 개선하는 데 중요한 역할을 합니다. 예를 들어 2024년 6월, 미국에 본부를 둔 미용성형외과 전문의 전문단체인 국제미용성형외과학회(ISAPS)는 2023년 수술 건수가 5.5% 증가하여 전 세계에서 1,580만 건 이상의 수술과 1,910만 건 이상의 비수술적 수술이 이루어졌다고 보고했습니다. 이러한 추세는 수술 건수 증가가 지혈제 및 조직 실란트 수요를 촉진하고 있음을 지원합니다.
지혈제 및 조직 실란트 시장의 주요 기업은 수술 치료의 효과와 효율성을 높이기 위해 즉시 사용 가능한 흡수성 콜라겐 패드와 같은 혁신적인 제품 개발에 우선순위를 두고 있습니다. 이 콜라겐 기반 지혈제는 생물학적 활성 재흡수성 물질을 사용하여 설계되었으며, 준비할 필요 없이 효과적인 조직 봉쇄 및 지혈을 위해 즉시 사용할 수 있습니다. 2025년 4월, 미국 헬스케어 기업 박스터 인터내셔널(Baxter International)은 오스트리아에서 열린 심포지엄에서 헤모패치 지혈제를 발표했습니다. 이 신제품은 상온 보관용으로 설계되어 예열이 필요 없고, 바로 사용할 수 있는 편리함을 가지고 있습니다. 개복 수술과 최소 침습 수술 모두에 적합하며 냉장 보관 및 추가 준비가 필요하지 않습니다. 헤모패치의 강력한 접착력, 보존 기간 연장, 빠른 지혈 반응으로 수술 중 출혈과 누출을 보다 효율적으로 제어할 수 있으며, 다양한 전문 분야에서 수술 정확도 향상과 환자 회복 결과 개선에 기여합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 지혈제 및 조직 실란트 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 지혈제 및 조직 실란트 시장 : 성장률 분석
세계의 지혈제 및 조직 실란트 시장 실적 : 규모와 성장, 2019-2024
세계의 지혈제 및 조직 실란트 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 지혈제 및 조직 실란트 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 지혈제 및 조직 실란트 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
국소 지혈제
접착제 및 조직 실란트
피브린 실란트
기타 제품 유형
세계의 지혈제 및 조직 실란트 시장 : 성분별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
생물학 기반
합성 기반
조합
세계의 지혈제 및 조직 실란트 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
직접 판매
판매 대리점
온라인 판매
세계의 지혈제 및 조직 실란트 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
외과수술
외상 증례
심장혈관 외과
일반 외과
기타 용도
세계의 지혈제 및 조직 실란트 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
외래 수술 센터(ASC)
전문 클리닉
조사·학술기관
세계의 지혈제 및 조직 실란트 시장 : 서브 세분화, 국소 지혈제(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
기계식 지혈 겸자
액티브 지혈제
유동성 지혈재
복합 지혈 겸자
세계의 지혈제 및 조직 실란트 시장 : 서브 세분화, 접착제 및 조직 실란트(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
합성 조직 접착제
생체 조직 접착제
시아노아크릴레이트계 접착제
세계의 지혈제 및 조직 실란트 시장 : 서브 세분화, 피브린 실란트(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
액체 피브린 실란트
패치 기반 피브린 실란트
세계의 지혈제 및 조직 실란트 시장 : 서브 세분화, 기타 제품 유형(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
젤라틴 기반 지혈제
콜라겐 기반 지혈제
산화 재생 셀룰로오스계 지혈재
제7장 지역별·국가별 분석
세계의 지혈제 및 조직 실란트 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 지혈제 및 조직 실란트 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
지혈제 및 조직 실란트 시장 : 경쟁 구도
지혈제 및 조직 실란트 시장 : 기업 개요
Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
Becton, Dickinson and Company(BD) Overview, Products and Services, Strategy and Financial Analysis
Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Meril Life Sciences Pvt. Ltd.
Teleflex Incorporated
Integra LifeSciences Holdings Corporation
Corza Medical Inc.
Artivion Inc.
Ethicon Inc.
Advanced Medical Solutions Group plc
Marine Polymer Technologies Inc.
Samyang Holdings Corporation
3-D Matrix Medical Technology Co Ltd.
GELITA AG
BioCer Entwicklungs-GmbH
AEGIS Lifesciences Pvt. Ltd.
Betatech Medical Ltd.
Cohera Medical Inc
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
지혈제 및 조직 실란트 시장 2029 : 새로운 기회를 제공하는 국가
지혈제 및 조직 실란트 시장 2029 : 새로운 기회를 제공하는 부문
지혈제 및 조직 실란트 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Hemostats and tissue sealants are products utilized during surgical procedures to manage bleeding (hemostasis) and seal tissues, thereby preventing the leakage of fluids like blood or air. Hemostats function by either encouraging clot formation or physically clamping blood vessels to halt bleeding, while tissue sealants are used to close wounds or surgical cuts, supporting quicker healing and lowering the likelihood of complications.
The primary categories of hemostats and tissue sealants include topical hemostats, adhesives and tissue sealants, fibrin sealants, and others. Topical hemostats are substances or materials directly applied to bleeding areas to control bleeding during surgeries or traumatic injuries. These are formulated from biological-based, synthetic-based, or combined materials, and are distributed through various channels such as direct sales, distributors, and online platforms. Their applications span across surgical procedures, trauma care, cardiovascular and general surgeries, among others, and they serve multiple end users including hospitals, ambulatory surgical centers (ASCs), specialty clinics, and academic and research institutions.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The hemostats and tissue sealants market research report is one of a series of new reports from The Business Research Company that provides hemostats and tissue sealants market statistics, including hemostats and tissue sealants industry global market size, regional shares, competitors with a hemostats and tissue sealants market share, hemostats and tissue sealants market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats and tissue sealants industry. This hemostats and tissue sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hemostats and tissue sealants market size has grown strongly in recent years. It will grow from $4.07 billion in 2024 to $4.35 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be credited to an expanding elderly population, a higher occurrence of trauma and accidents, a growing prevalence of cardiovascular diseases, increased investments in the medical field, and a rising preference for minimally invasive surgical procedures.
The hemostats and tissue sealants market size is expected to see strong growth in the next few years. It will grow to $5.61 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be attributed to the increasing use of hemostats in ambulatory surgical centers, rising demand for biocompatible and synthetic sealants, greater investments in surgical innovation and research and development, heightened awareness of blood management during surgeries, and growing healthcare spending. Key trends expected during this period include progress in synthetic polymer technologies, innovation in drug-delivery-based sealants, incorporation of hemostatic agents into minimally invasive procedures, advancements in dual-function sealants and hemostats, and the development of bioengineered and biocompatible materials.
The growing number of surgical procedures is expected to drive the expansion of the hemostats and tissue sealants market. Surgical procedures involve manual and instrumental techniques performed by surgeons to diagnose, treat, or remove diseased tissues or organs, or to restore bodily functions. The increase in these procedures is largely attributed to the rising prevalence of chronic diseases, which frequently require surgical intervention for proper management, treatment, or to prevent complications. Hemostats and tissue sealants play a crucial role in these procedures by effectively controlling bleeding and sealing tissues, thereby minimizing complications and enhancing surgical outcomes. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a U.S.-based professional organization for board-certified aesthetic plastic surgeons, reported a 5.5% increase in surgical procedures in 2023, with over 15.8 million surgeries and 19.1 million non-surgical procedures conducted worldwide. This trend underscores how the increasing number of surgical procedures is fueling the demand for hemostats and tissue sealants.
Leading companies in the hemostats and tissue sealants market are prioritizing the development of innovative products, such as ready-to-use absorbable collagen pads, to enhance the effectiveness and efficiency of surgical care. These collagen-based hemostats are designed using bioactive, resorbable materials that require no preparation, offering immediate application for effective tissue sealing and hemostasis. In April 2025, Baxter International Inc., a U.S.-based healthcare company, introduced the Hemopatch Sealing Hemostat at a symposium in Austria. This new product is designed for room temperature storage and offers the convenience of being ready-to-use without the need for pre-warming. It is suitable for both open and minimally invasive surgeries and eliminates the need for refrigeration or additional preparation. The Hemopatch's strong adhesive capabilities, extended shelf life, and rapid hemostatic response enable more efficient bleeding and leakage control during surgery, contributing to improved surgical precision and better patient recovery outcomes across various specialties.
In March 2024, Advanced Medical Solutions Group PLC, a UK-based medical technology company, acquired Peters Surgical SAS for $154.6 million. This acquisition is aimed at expanding Advanced Medical Solutions' surgical product portfolio, reinforcing its footprint in key European markets, and enhancing its position in the global wound care and closure technologies sector. Peters Surgical SAS, based in France, specializes in producing medical devices and instruments focused on hemostats and tissue sealants.
Major players in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., and Cohera Medical Inc.
North America was the largest region in the hemostats and tissue sealants market in 2024. The regions covered in hemostats and tissue sealants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the hemostats and tissue sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The hemostats and tissue sealants market consists of sales of gelatin-based hemostats, fibrin sealants, oxidized regenerated cellulose, thrombin-based hemostats, and cyanoacrylate-based tissue adhesives. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hemostats And Tissue Sealants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hemostats and tissue sealants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for hemostats and tissue sealants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemostats and tissue sealants market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Topical Hemostats; Adhesives And Tissue Sealants; Fibrin Sealants; Other Product Types
2) By Composition: Biological Based; Synthetic Based; Combination
3) By Distribution Channel: Direct Sales; Distributors; Online Sales
4) By Application: Surgical Procedures; Trauma Cases; Cardiovascular Surgery; General Surgery; Other Applications
5) By End-Users: Hospitals; Ambulatory Surgical Centers (ASCs); Specialized Clinics; Research And Academic Institutes
Subsegments:
1) By Topical Hemostats: Mechanical Hemostats; Active Hemostats; Flowable Hemostats; Combination Hemostats
2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives; Biological Tissue Adhesives; Cyanoacrylate-Based Adhesives
3) By Fibrin Sealants: Liquid Fibrin Sealants; Patch-Based Fibrin Sealants
4) By Other Product Types: Gelatin-Based Hemostats; Collagen-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats
Companies Mentioned: Johnson & Johnson; Medtronic plc; Becton, Dickinson and Company (BD); Stryker Corporation; Baxter International Inc.; Meril Life Sciences Pvt. Ltd.; Teleflex Incorporated; Integra LifeSciences Holdings Corporation; Corza Medical Inc.; Artivion Inc.; Ethicon Inc.; Advanced Medical Solutions Group plc; Marine Polymer Technologies Inc.; Samyang Holdings Corporation; 3-D Matrix Medical Technology Co Ltd.; GELITA AG; BioCer Entwicklungs-GmbH; AEGIS Lifesciences Pvt. Ltd.; Betatech Medical Ltd.; Cohera Medical Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Hemostats And Tissue Sealants Market Characteristics
3. Hemostats And Tissue Sealants Market Trends And Strategies
4. Hemostats And Tissue Sealants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Hemostats And Tissue Sealants Growth Analysis And Strategic Analysis Framework
5.1. Global Hemostats And Tissue Sealants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Hemostats And Tissue Sealants Market Growth Rate Analysis
5.4. Global Hemostats And Tissue Sealants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Hemostats And Tissue Sealants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Hemostats And Tissue Sealants Total Addressable Market (TAM)
6. Hemostats And Tissue Sealants Market Segmentation
6.1. Global Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Hemostats
Adhesives And Tissue Sealants
Fibrin Sealants
Other Product Types
6.2. Global Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biological Based
Synthetic Based
Combination
6.3. Global Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Direct Sales
Distributors
Online Sales
6.4. Global Hemostats And Tissue Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgical Procedures
Trauma Cases
Cardiovascular Surgery
General Surgery
Other Applications
6.5. Global Hemostats And Tissue Sealants Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers (ASCs)
Specialized Clinics
Research And Academic Institutes
6.6. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Topical Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mechanical Hemostats
Active Hemostats
Flowable Hemostats
Combination Hemostats
6.7. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Adhesives And Tissue Sealants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Synthetic Tissue Adhesives
Biological Tissue Adhesives
Cyanoacrylate-Based Adhesives
6.8. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Fibrin Sealants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Liquid Fibrin Sealants
Patch-Based Fibrin Sealants
6.9. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gelatin-Based Hemostats
Collagen-Based Hemostats
Oxidized Regenerated Cellulose-Based Hemostats
7. Hemostats And Tissue Sealants Market Regional And Country Analysis
7.1. Global Hemostats And Tissue Sealants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Hemostats And Tissue Sealants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Hemostats And Tissue Sealants Market
8.1. Asia-Pacific Hemostats And Tissue Sealants Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Hemostats And Tissue Sealants Market
9.1. China Hemostats And Tissue Sealants Market Overview
9.2. China Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Hemostats And Tissue Sealants Market
10.1. India Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Hemostats And Tissue Sealants Market
11.1. Japan Hemostats And Tissue Sealants Market Overview
11.2. Japan Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Hemostats And Tissue Sealants Market
12.1. Australia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Hemostats And Tissue Sealants Market
13.1. Indonesia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Hemostats And Tissue Sealants Market
14.1. South Korea Hemostats And Tissue Sealants Market Overview
14.2. South Korea Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Hemostats And Tissue Sealants Market
15.1. Western Europe Hemostats And Tissue Sealants Market Overview
15.2. Western Europe Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Hemostats And Tissue Sealants Market
16.1. UK Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Hemostats And Tissue Sealants Market
17.1. Germany Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Hemostats And Tissue Sealants Market
18.1. France Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Hemostats And Tissue Sealants Market
19.1. Italy Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Hemostats And Tissue Sealants Market
20.1. Spain Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Hemostats And Tissue Sealants Market
21.1. Eastern Europe Hemostats And Tissue Sealants Market Overview
21.2. Eastern Europe Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Hemostats And Tissue Sealants Market
22.1. Russia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Hemostats And Tissue Sealants Market
23.1. North America Hemostats And Tissue Sealants Market Overview
23.2. North America Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Hemostats And Tissue Sealants Market
24.1. USA Hemostats And Tissue Sealants Market Overview
24.2. USA Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Hemostats And Tissue Sealants Market
25.1. Canada Hemostats And Tissue Sealants Market Overview
25.2. Canada Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Hemostats And Tissue Sealants Market
26.1. South America Hemostats And Tissue Sealants Market Overview
26.2. South America Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Hemostats And Tissue Sealants Market
27.1. Brazil Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Hemostats And Tissue Sealants Market
28.1. Middle East Hemostats And Tissue Sealants Market Overview
28.2. Middle East Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Hemostats And Tissue Sealants Market
29.1. Africa Hemostats And Tissue Sealants Market Overview
29.2. Africa Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Hemostats And Tissue Sealants Market Competitive Landscape And Company Profiles
30.1. Hemostats And Tissue Sealants Market Competitive Landscape
30.2. Hemostats And Tissue Sealants Market Company Profiles
30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Becton, Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Hemostats And Tissue Sealants Market Other Major And Innovative Companies
31.1. Meril Life Sciences Pvt. Ltd.
31.2. Teleflex Incorporated
31.3. Integra LifeSciences Holdings Corporation
31.4. Corza Medical Inc.
31.5. Artivion Inc.
31.6. Ethicon Inc.
31.7. Advanced Medical Solutions Group plc
31.8. Marine Polymer Technologies Inc.
31.9. Samyang Holdings Corporation
31.10. 3-D Matrix Medical Technology Co Ltd.
31.11. GELITA AG
31.12. BioCer Entwicklungs-GmbH
31.13. AEGIS Lifesciences Pvt. Ltd.
31.14. Betatech Medical Ltd.
31.15. Cohera Medical Inc
32. Global Hemostats And Tissue Sealants Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Hemostats And Tissue Sealants Market
34. Recent Developments In The Hemostats And Tissue Sealants Market
35. Hemostats And Tissue Sealants Market High Potential Countries, Segments and Strategies
35.1 Hemostats And Tissue Sealants Market In 2029 - Countries Offering Most New Opportunities
35.2 Hemostats And Tissue Sealants Market In 2029 - Segments Offering Most New Opportunities
35.3 Hemostats And Tissue Sealants Market In 2029 - Growth Strategies
